In the news: Sanofi under investigation, Singapore upholds PRC judgment and automaker probe

| BY

clpstaff &clp articles

French drug maker Sanofi is being investigated for bribery, the Singapore High Court has upheld a judgment from a Chinese court for $190,000 and the China Automobile Association has begun a probe into the pricing of foreign car makers

Sanofi prepares for bribery investigation

French drug maker Sanofi has become the next target in China's crackdown against bribery. Sanofi staff paid bribes totalling Rmb1.7 million ($278000) to 503 doctors at 97 hospitals in Shanghai, Beijing, Hangzhou and Guangzhou in 2007, according to an anonymous whistleblower speaking to the 21st Century Business Herald. Xinhua has cited a health bureau official saying disciplinary authorities and the Beijing municipal health bureau are investigating the French company.

Source: Reuters

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]